iBio highlights primate study data for IBIO-610
The company said non-human primate study data support IBIO-610’s potential to preserve muscle when combined with GLP-1 therapy.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
The company said non-human primate study data support IBIO-610’s potential to preserve muscle when combined with GLP-1 therapy.